Not applicableUnknownNCT06142175What this trial is testingRelmacabtagene Autoleucel in Patients With LBCLWho this might be right forLarge B-cell Lymphoma Shanghai Ming Ju Biotechnology Co., Ltd. 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07447726What this trial is testingExploratory Clinical Study on the Safety and Efficacy of CD19X CAR-T Cell Injection in the Treatment of Relapsed/Refractory Large B-Cell LymphomaWho this might be right forLarge B-Cell Lymphoma (LBCL) Institute of Hematology & Blood Diseases Hospital, China 3
Not applicableLooking for participantsNCT07524816What this trial is testingReal World Practice With Academic Anti CD19 CAR-T Cell Therapy in Relapse/Refractory B-cell LymphomaWho this might be right forLarge B-Cell Lymphoma (LBCL) N.N. Alexandrov National Cancer Centre 76
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07594899What this trial is testingAI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCLWho this might be right forLarge B-Cell Lymphoma (LBCL) Ruijin Hospital 178
Testing effectiveness (Phase 2)Looking for participantsNCT06526793What this trial is testingSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHLWho this might be right forB-cell Non-Hodgkin LymphomaFollicular Lymphoma (FL)Large B-Cell Lymphoma (LBCL) AstraZeneca 270
Not applicableUnknownNCT05800067What this trial is testingAxi-cel Retreatment in Relapsed/Refractory LBCLWho this might be right forCAR-T Retreatment Ruijin Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT07514169What this trial is testingThe Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCLWho this might be right forLarge B-Cell Lymphoma (LBCL) Ruijin Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07269639What this trial is testingGolcadomide, Poseltinib, and Rituximab for Relapsed/Refractory Diffuse Large B-cell LymphomaWho this might be right forLarge B-Cell Lymphoma (LBCL) Seoul National University Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07240194What this trial is testingThe Efficacy and Safety of Glofitamab in Combination With PD-1 Antibody and Lenalidomide in Patients With Relapsed/Refractory Large B-cell Lymphoma (LBCL) With TP53 Aberrations: A Prospective, Multicenter, Phase II Clinical StudyWho this might be right forLarge B-cell LymphomaTP53 The First Affiliated Hospital with Nanjing Medical University 24
Early research (Phase 1)Ended earlyNCT06256484What this trial is testingEvaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin LymphomaWho this might be right forRelapsed/Refractory B-cell Non-Hodgkin Lymphoma Atara Biotherapeutics 1
Testing effectiveness (Phase 2)UnknownNCT06149169What this trial is testingCD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell LymphomaWho this might be right forLymphoma, Non-HodgkinDiffuse Large B Cell Lymphoma Shanghai Ming Ju Biotechnology Co., Ltd. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT07461831What this trial is testingCD19/ CD22 Bispecific CAR-T Cell Therapy for Relapsed/ Refractory Large B-cell LymphomaWho this might be right forLarge B-Cell Lymphoma (LBCL) Beijing Tongren Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07774234What this trial is testingSonrotoclax, Glofitamab, Gemcitabine, and Oxaliplatin for Relapsed or Refractory Large B-Cell LymphomaWho this might be right forLarge B-Cell Lymphoma (LBCL)High-grade B-cell Lymphoma The First Affiliated Hospital of Soochow University 39
Early research (Phase 1)Study completedNCT05359211What this trial is testingNKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell LymphomaWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Grade 3b Follicular Lymphoma+6 more Fred Hutchinson Cancer Center 27
Testing effectiveness (Phase 2)Looking for participantsNCT04661020What this trial is testingCD19 CAR-T Therapy for Patients With Newly Diagnosed High-risk Large B-cell LymphomaWho this might be right forLarge B-Cell Lymphoma (LBCL) Zhejiang University 40
Large-scale testing (Phase 3)Looking for participantsNCT07215585What this trial is testingAZD0486 1L Therapy for Elderly or Unfit Participants With LBCLWho this might be right forLarge B-cell Lymphoma AstraZeneca 420
Large-scale testing (Phase 3)Active Not RecruitingNCT05605899What this trial is testingStudy to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell LymphomaWho this might be right forHigh-risk Large B-cell Lymphoma (LBCL) Kite, A Gilead Company 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07602322What this trial is testingLME-Guided Precision Combination Therapy in B-cell Lymphoma Patients After CD19 CAR-T FailureWho this might be right forLarge B-cell Lymphoma Ruijin Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07717177What this trial is testingAI-Driven Treatment Strategy vs ZR2 in Older Treatment-naive Patients With LBCLWho this might be right forLarge B-Cell Lymphoma (LBCL) Ruijin Hospital 112
Testing effectiveness (Phase 2)Ended earlyNCT00361621What this trial is testingPh II CHOP+Velcade in Mediastinal LBCLWho this might be right forNon-Hodgkin's Lymphoma Dana-Farber Cancer Institute 3